Cardiff Oncology, Inc.

CAPSTONE INVESTMENT ADVISORS, LLC CRDF

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

Shares

51,190

Value ($000)

144

Weight

0.0%

2020 Q4 - 2025 Q4 (21 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	144	0.0%	51,190	12/31/2025
2025 Q3	11/14/2025	105	0.0%	51,190	9/30/2025
2025 Q2	8/14/2025	161	0.0%	51,190	6/30/2025
2025 Q1	5/15/2025	161	0.0%	51,190	3/31/2025
2024 Q4	2/14/2025	222	0.0%	51,190	12/31/2024
2024 Q3	11/14/2024	137	0.0%	51,190	9/30/2024
2024 Q2	8/14/2024	114	0.0%	51,190	6/30/2024
2024 Q1	5/1/2024	273	0.0%	51,190	3/31/2024
2023 Q4	2/12/2024	76	0.0%	51,190	12/31/2023
2023 Q3	11/13/2023	71	0.0%	51,190	9/30/2023
2023 Q2	8/10/2023	75	0.0%	51,190	6/30/2023
2023 Q1	5/9/2023	84	0.0%	51,190	3/31/2023
2022 Q4	2/10/2023	72	0.0%	51,190	12/31/2022
2022 Q3	11/10/2022	79	0.0%	51,190	9/30/2022
2022 Q2	8/15/2022	113	0.0%	51,190	6/30/2022
2022 Q1	5/13/2022	127	0.0%	51,190	3/31/2022
2021 Q4	2/11/2022	308	0.0%	51,190	12/31/2021
2021 Q3	11/15/2021	349	0.0%	52,349	9/30/2021
2021 Q2	2/11/2022	340	0.0%	51,190	6/30/2021
2021 Q1	2/11/2022	530	0.0%	57,220	3/31/2021
2020 Q4	6/21/2021	2,245	0.1%	124,788	12/31/2020